Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Colombia University Medical Center
mi
from
New York, NY
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Colombia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
CUMC Research Pharmacy
mi
from
New York, NY
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
CUMC Research Pharmacy
mi
from
New York, NY
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
AGA Clinical Research Associates, LLC
mi
from
Egg Harbor Township, NJ
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
AGA Clinical Research Associates, LLC
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Ertan Digestive Disease Center at Memorial Hermann Hospital
mi
from
Houston, TX
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Ertan Digestive Disease Center at Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Advanced Gatroenterology Center
mi
from
Port Orange, FL
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Advanced Gatroenterology Center
mi
from
Port Orange, FL
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Georgia Endoscopy Center (COLONOSCOPY)
mi
from
Alpharetta, GA
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Georgia Endoscopy Center (COLONOSCOPY)
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Alpine Medical Group
mi
from
Salt Lake City, UT
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Alpine Medical Group
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Wisconsin Center for Advanced Research, a division of GI Associates, LLC
mi
from
Milwaukee, WI
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Wisconsin Center for Advanced Research, a division of GI Associates, LLC
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Chevy Chase Endoscopy Center
mi
from
Chevy Chase, MD
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Chevy Chase Endoscopy Center
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Baylor St. Luke's Medical Center Endoscopy - McNair Campus
mi
from
Houston, TX
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Baylor St. Luke's Medical Center Endoscopy - McNair Campus
mi
from
Houston, TX
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Investigational Drug Service Pharmacy
mi
from
La Jolla, CA
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Investigational Drug Service Pharmacy
mi
from
La Jolla, CA
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Connecticut Clinical Research Institute
mi
from
Bristol, CT
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Connecticut Clinical Research Institute
mi
from
Bristol, CT
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Eastside Endoscopy Center
mi
from
Macomb, MI
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Eastside Endoscopy Center
mi
from
Macomb, MI
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
GI Clinical Research
mi
from
Nashville, TN
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
GI Clinical Research
mi
from
Nashville, TN
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center 1
mi
from
New York, NY
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center 1
mi
from
New York, NY
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Cotton-O'Neil Clinical Research Center
mi
from
Topeka, KA
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Cotton-O'Neil Clinical Research Center
mi
from
Topeka, KA
Click here to add this to my saved trials
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated:  12/31/1969
Huron Gastroenterology Associates / Center for Digestive Care
mi
from
Ypsilanti, MI
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Status: Enrolling
Updated: 12/31/1969
Huron Gastroenterology Associates / Center for Digestive Care
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Mind-Body Medicine and Ulcerative Colitis
Mind-Body Medicine and Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Mind-Body Medicine and Ulcerative Colitis
Mind-Body Medicine and Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
UCLA Medical Center
mi
from
Los Angeles, CA
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Connecticut Children's Medical Center
mi
from
Hartford, CT
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Nemours Children's Clinic
mi
from
Jacksonville, FL
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Emory Children's Center
mi
from
Atlanta, GA
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Emory Children's Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Riley Children's Hospital
mi
from
Indianapolis, IN
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
John Hopkins Children's Hospital
mi
from
Baltimore, MD
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
John Hopkins Children's Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Goryeb Children's Hospital / Atlantic Health
mi
from
Morristown, NJ
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Goryeb Children's Hospital / Atlantic Health
mi
from
Morristown, NJ
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Women and Children's Hospital of Buffalo
mi
from
Buffalo, NY
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Women and Children's Hospital of Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Cohen Children's Medical Center
mi
from
New Hyde Park, NY
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Cohen Children's Medical Center
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Morgan Stanley Children's Hospital
mi
from
New York, NY
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Morgan Stanley Children's Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Mt Sinai Hospital
mi
from
New York, NY
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Mt Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Golisano Children's Hospital SUNY Upstate Medical University
mi
from
Syracuse, NY
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Golisano Children's Hospital SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Hasbro Children's Hospital
mi
from
Providence, RI
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Hasbro Children's Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Monroe Carell Jr. Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Monroe Carell Jr. Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
UT Southwestern
mi
from
Dallas, TX
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
UT Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Primary Children's Medical Center - University of Utah
mi
from
Salt Lake City, UT
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Primary Children's Medical Center - University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Boston
mi
from
Boston, MA
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
IWK Health Centre
mi
from
Halifax,
Predicting Response to Standardized Pediatric Colitis Therapy
Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
IWK Health Centre
mi
from
Halifax,
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Alliance Clinical Research
mi
from
Oceanside, CA
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Alliance Clinical Research
mi
from
Oceanside, CA
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials